DIVA Laboratories (4153.TWO) Stock Price
DIVA Laboratories Price
Revenue at DIVA Laboratories has contracted by 0.1% per year over the past 18 years to 868.84 M TWD. Earnings per share have grown at 7.2% per year over the last 18 years. DIVA Laboratories's net margin stands at 10.4%, up from 3.1% several years earlier. DIVA Laboratories currently offers a dividend yield of about 6.47%. The payout ratio is around 132% of earnings. The dividend has grown at 75.5% per year over the past 3 years.
DIVA Laboratories stock price
DIVA Laboratories business model & stock analysis
Frequently asked questions about DIVA Laboratories
Converted at the current exchange rate, the DIVA Laboratories share trades at 0.86 EUR (30.90 TWD).
The expected revenue of DIVA Laboratories is 1.18 B TWD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of DIVA Laboratories is 118.87 M TWD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of DIVA Laboratories is currently 15.51. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the DIVA Laboratories stock.
The price-to-sales ratio (P/S) of DIVA Laboratories is currently 1.57. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the DIVA Laboratories stock.
The Eulerpool Quality Score for DIVA Laboratories is 1/10.
The ISIN of DIVA Laboratories is TW0004153002. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of DIVA Laboratories is 4153.TWO. The ticker symbol is used to trade DIVA Laboratories shares on the stock exchange.
DIVA Laboratories stock
DIVA Laboratories Peer Group
DIVA Laboratories FIGI
All fundamentals and in-depth analysis of DIVA Laboratories
Our stock analysis for DIVA Laboratories stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DIVA Laboratories. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.